[Home](https://github.com/mm80843/T3.5/blob/pages/index.md) >> Class: [Risk](https://github.com/mm80843/T3.5/tree/pages/docs/Risk/index.md) >> Individual ID:PBN__Risk_292 

# __Enteric involvement in covid-19 patients__

## Articles mentionning the risk

* [SARS-CoV-2 in wastewater: potential health risk, but also data source](https://github.com/mm80843/T3.5/blob/pages/Article/PBN__Article_70.md)

## Category to which it belongs

* [The wide-ranging impacts of the covid-19 pandemic, from its spread in urban areas to its economic, social, and psychological consequences, call for urgent and effective crisis management.](https://github.com/mm80843/T3.5/blob/pages/PBNCategory/PBN__PBNCategory_69.md)

## Closest similar item

* [About covid-19](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_290.md)
* [Aggravating covid-19](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_2493.md)
* [Covid-19 infection](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_2900.md)
* [Difficulty in confinement of covid-19 patients](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_824.md)
* [Faecal-oral transmission of covid-19](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_704.md)
* [Gastrointestinal symptoms in covid-19 patients](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_1647.md)
* [Hospital-acquired covid-19](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_3081.md)
* [Potential enteric transmission of covid-19](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_691.md)
* [Severe cases of covid-19](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_3381.md)
* [Spread of covid-19 through faecal-oral route](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_535.md)

## Description of the risk

Evidence of gastrointestinal symptoms and enteric involvement in COVID-19 patients.

## Is the risk affecting GBN scales

* [No](https://github.com/mm80843/T3.5/blob/pages/ISO_Scale/PBN__ISO_Scale_0.md)

## Mitigations of this risk

* [Attention to liver transplant recipients with metabolic comorbidities](https://github.com/mm80843/T3.5/blob/pages/Mitigation/PBN__Mitigation_2212.md)
* [Monitor and manage gastrointestinal symptoms, enhance diagnostic capabilities](https://github.com/mm80843/T3.5/blob/pages/Mitigation/PBN__Mitigation_365.md)

## Name of the risk

Increased severity, complications in diagnosis and treatment

## People affected by this risk

* [Hospitalized covid-19 patients](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_1087.md)

## Stakeholders who can mitigate this risk

* [Healthcare providers](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_121.md)
* [Medical centers](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_1088.md)

## Technologies linked to the risk

* [Diagnostic tests](https://github.com/mm80843/T3.5/blob/pages/Technology/PBN__Technology_1000.md)
* [Gastrointestinal monitoring tools](https://github.com/mm80843/T3.5/blob/pages/Technology/PBN__Technology_999.md)

## This Risk belongs to this RiskGroup

* [Public health risks](https://github.com/mm80843/T3.5/blob/pages/RiskGroup/PBN__RiskGroup_3.md)

## This Risk belongs to this RiskSubgroup

* [Failure to implement preventive measures](https://github.com/mm80843/T3.5/blob/pages/RiskSubgroup/PBN__RiskSubgroup_12.md)

## Type of impact of the risk (according to ISO37100)

* [Health and care](https://github.com/mm80843/T3.5/blob/pages/ISO_Purpose/PBN__ISO_Purpose_0.md)

## Type of purpose of the risk (according to ISO37100)

* [Resilience](https://github.com/mm80843/T3.5/blob/pages/ISO_Impact/PBN__ISO_Impact_2.md)

## Type of the risk

* [Physical](https://github.com/mm80843/T3.5/blob/pages/RiskHealth/PBN__RiskHealth_0.md)

## Property: has_RiskType

* [Health](https://github.com/mm80843/T3.5/blob/pages/RiskType/PBN__RiskType_4.md)

